United States· US:71205-576_e9946b03-ade7-4c74-b94d-78c966bb0c89

Cefdinir

A cefdinir product containing cefdinir, registered in United States by Proficient Rx LP. The same ATC class is registered in 3 of our 19 countries.

ATC J01DD15Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCefdinirATCJ01DD15REGISTER NO.US:71205-576_e9946b03…PACKS LISTED7CHECKEDSeptember 12, 2026

Where it is registered

Cefdinir is registered in 3 of 19 countries.

Countries holding a registration under ATC J01DD15 (cefdinir), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 2 of them publish a price we can compare per daily dose

Cefdinir · ATC J01DD15

3 / 19 countries

  • Finlandprice
  • Japan
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
Cefdinir
Manufacturer
Proficient Rx LP
Country
United States (US)
ATC code
J01DD15
ATC class
Cefdinir
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 7

  • ndc11
    7120557606
    6 CAPSULE in 1 BOTTLE (71205-576-06)
  • ndc11
    7120557610
    10 CAPSULE in 1 BOTTLE (71205-576-10)
  • ndc11
    7120557614
    14 CAPSULE in 1 BOTTLE (71205-576-14)
  • ndc11
    7120557620
    20 CAPSULE in 1 BOTTLE (71205-576-20)
  • ndc11
    7120557630
    30 CAPSULE in 1 BOTTLE (71205-576-30)
  • ndc11
    7120557660
    60 CAPSULE in 1 BOTTLE (71205-576-60)
  • ndc11
    7120557690
    90 CAPSULE in 1 BOTTLE (71205-576-90)

Regulatory notes

UNII (FDA substance ID)
CI0FAO63WC
CEFDINIR
RxCUI 25037
Orange Book
A210220
AB
DailyMed SPL labels
1 version tracked

Interactions

110 interactions on record for cefdinir.

Graded by severity as the source publishes them — 24 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cefdinir · interactions on record

110 records

  • 24 moderate
  • 86 info

Most severe, free to view

  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate
  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cefdinir in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cefdinir products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f805cb58-e42f-43ec-a00f-46db8d5573bb
GET /v1/drugs/f805cb58-e42f-43ec-a00f-46db8d5573bb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "CI0FAO63WC",
    "rxcui": "25037",
    "inchikey": "RTXOFQZKPXMALH-GHXIOONMSA-N",
    "display_name": "CEFDINIR",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 4
  },
  "spl_meta": {
    "a8029f7c-6353-46db-8c8c-c86a9485a14f": {
      "match": "brand_token",
      "title": "CEFDINIR CAPSULE [REMEDYREPACK INC.]",
      "spl_version": "5",
      "published_date": "2026-05-20"
    }
  },
  "productid": "71205-576_e9946b03-ade7-4c74-b94d-78c966bb0c89",
  "productndc": "71205-576",
  "dosage_form": "CAPSULE",
  "orange_book": {
    "appl_no": "210220",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "300MG",
        "product_no": "001",
        "approval_date": "Feb 19, 2021"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "CEFDINIR",
  "proprietary_name": "Cefdinir",
  "active_ingred_unit": "mg/1",
  "application_number": "ANDA210220",
  "marketing_category": "ANDA",
  "nonproprietary_name": "Cefdinir",
  "start_marketing_date": "20210220",
  "active_numerator_strength": "300"
}

See everything about cefdinir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.